타크로리무스 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

The tacrolimus market size is expected to reach USD 9,683.26 million by 2032, according to a new study by Polaris Market Research. The report "Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing organ transplantation rates drive the tacrolimus market growth. Tacrolimus is a potent immunosuppressive drug extensively used in transplant patients to prevent the rejection of newly transplanted organs. The continuous advancements in medical research and pharmaceuticals within the tacrolimus market have significantly contributed to improving patient outcomes post-transplantation. These developments have not only enhanced the efficacy of tacrolimus but have also led to the development of more targeted and personalized approaches to immunosuppression. The increasing availability and accessibility of tacrolimus, a medication used to prevent organ rejection after transplantation, has led to a favorable increase in organ transplantation rates. Efforts to simplify transplantation procedures and educate the public on organ donation have also contributed to the tacrolimus market growth.

The advancements in organ transplantation procedures foster the tacrolimus market growth. The need for immunosuppressants has been on the rise due to advancements in minimally invasive transplant procedures, improved organ preservation methods, and higher success rates of transplants. Tacrolimus has emerged as a crucial medication in transplantation medicine because of its effectiveness and fewer side effects in comparison to traditional drugs. With advancements in surgical techniques and post-transplant care, the use of immunosuppressive drugs such as tacrolimus has increased. The demand for tacrolimus has increased due to the growing number of transplant surgeries and the wider acceptance of transplantation as an effective treatment for various medical conditions.

As the geriatric population grows, the demand for medications like tacrolimus is expected to increase. This is because older adults often require organ transplants or face immune-related disorders. Healthcare systems are adapting to meet the evolving healthcare needs of this aging demographic, creating a significant market opportunity for tacrolimus manufacturers and suppliers.

Tacrolimus Market Report Highlights

The tablets and capsules segment held the largest market share in 2023 due to tacrolimus being favorable and easy for patients to consume, ensuring better compliance with medication regimens.

The immunosuppression segment dominated the market in 2023 due to the rising number of organ transplant surgeries.

North America dominated the tacrolimus market, owing to the surge in organ transplants and the presence of the key players in the region.

The key market players include Astellas Pharma Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Inc., GlaxoSmithKline plc, LEO Pharma A/S, Novartis AG, Lupin Pharmaceuticals Inc., Panacea Biotec, and Pfizer Inc.

Polaris Market Research has segmented the tacrolimus market report based on product, application, end-use, and region:

Polypropylene Nonwoven Fabrics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

• Injections
• Tablets and Capsules
• Others

Polypropylene Nonwoven Fabrics, Application Outlook (Revenue - USD Million, 2019 - 2032)

• Dermatitis
• Immunosuppression
• Others

Polypropylene Nonwoven Fabrics, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

• Clinics
• Hospitals
• Others

Polypropylene Nonwoven Fabrics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Australia
• Malaysia
• Rest of Asia Pacific
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa

Table of Contents

1.Introduction

• 1.1.Report Description
  • 1.1.1.Objectives of the Study
  • 1.1.2.Market Scope
  • 1.1.3.Assumptions
• 1.2.Stakeholders

2.Executive Summary

• 2.1.Market Highlights

3.Research Methodology

• 3.1.Overview
  • 3.1.1.Data Mining
• 3.2.Data Sources
  • 3.2.1.Primary Sources
  • 3.2.2.Secondary Sources

4.Global Tacrolimus Market Insights

• 4.1.Tacrolimus Market - End-Use Snapshot
• 4.2.Tacrolimus Market Dynamics
  • 4.2.1.Drivers and Opportunities
    • 4.2.1.1.Increasing research and development activities drive the tacrolimus market growth
    • 4.2.1.2.The increasing prevalence of autoimmune diseases facilitating the growth of the market
  • 4.2.2.Restraints and Challenges
    • 4.2.2.1.Side effects and the availability of the alternative treatments hampering on the tacrolimus market growth
• 4.3.Porter's Five Forces Analysis
  • 4.3.1.Bargaining Power of Suppliers (Moderate)
  • 4.3.2.Threats of New Entrants: (Low)
  • 4.3.3.Bargaining Power of Buyers (Moderate)
  • 4.3.4.Threat of Substitute (Moderate)
  • 4.3.5.Rivalry among existing firms (High)
• 4.4.PESTEL Analysis
• 4.5.Tacrolimus Market End-Use Trends
• 4.6.Value Chain Analysis
• 4.7.COVID-19 Impact Analysis

5.Global Tacrolimus Market, by Product Type

• 5.1.Key Findings
• 5.2.Introduction
  • 5.2.1.Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
• 5.3.Injections
  • 5.3.1.Global Tacrolimus Market, by Injections, by Region, 2019-2032 (USD Billion)
• 5.4.Tablets and Capsules
  • 5.4.1.Global Tacrolimus Market, by Tablets and Capsules, by Region, 2019-2032 (USD Billion)
• 5.5.Others
  • 5.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)

6.Global Tacrolimus Market, by Application

• 6.1.Key Findings
• 6.2.Introduction
  • 6.2.1.Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
• 6.3.Dermatitis
  • 6.3.1.Global Tacrolimus Market, by Dermatitis, by Region, 2019-2032 (USD Billion)
• 6.4.Immunosuppression
  • 6.4.1.Global Tacrolimus Market, by Immunosuppression, by Region, 2019-2032 (USD Billion)
• 6.5.Others
  • 6.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Tacrolimus Market, by End-Use

• 7.1.Key Findings
• 7.2.Introduction
  • 7.2.1.Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
• 7.3.Clinics
  • 7.3.1.Global Tacrolimus Market, by Clinics, By Region, 2019-2032 (USD Billion)
• 7.4.Hospitals
  • 7.4.1.Global Tacrolimus Market, by Hospitals, By Region, 2019-2032 (USD Billion)
• 7.5.Others
  • 7.5.1.Global Tacrolimus Market, by Others, By Region, 2019-2032 (USD Billion)

8.Global Tacrolimus Market, by Geography

• 8.1.Key findings
• 8.2.Introduction
  • 8.2.1.Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
• 8.3.Tacrolimus Market - North America
  • 8.3.1.North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 8.3.2.North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 8.3.3.North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.3.4.Tacrolimus Market - U.S.
    • 8.3.4.1.U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4.2.U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.4.3.U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.3.5.Tacrolimus Market - Canada
    • 8.3.5.1.Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5.2.Canada.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.5.3.Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
• 8.4.Tacrolimus Market - Europe
  • 8.4.1.Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.2.Europe.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 8.4.3.Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.4.Tacrolimus Market - UK
    • 8.4.4.1.UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4.2.UK.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.4.3.UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.5.Tacrolimus Market - France
    • 8.4.5.1.France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5.2.France.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.5.3.France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.6.Tacrolimus Market - Germany
    • 8.4.6.1.Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6.2.Germany.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.6.3.Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.7.Tacrolimus Market - Italy
    • 8.4.7.1.Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7.2.Italy.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.7.3.Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.8.Tacrolimus Market - Spain
    • 8.4.8.1.Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8.2.Spain.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.8.3.Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.9.Tacrolimus Market - Netherlands
    • 8.4.9.1.Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9.2.Netherlands.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.9.3.Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.10.Tacrolimus Market - Russia
    • 8.4.10.1.Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10.2.Russia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.10.3.Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
• 8.5.Tacrolimus Market - Asia Pacific
  • 8.5.1.Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.2.Asia Pacific.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 8.5.3.Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.4.Tacrolimus Market - China
    • 8.5.4.1.China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4.2.China.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.4.3.China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.5.Tacrolimus Market - India
    • 8.5.5.1.India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5.2.India.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.5.3.India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.6.Tacrolimus Market - Malaysia
    • 8.5.6.1.Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6.2.Malaysia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.6.3.Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.7.Tacrolimus Market - Japan
    • 8.5.7.1.Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7.2.Japan.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.7.3.Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.8.Tacrolimus Market - Indonesia
    • 8.5.8.1.Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8.2.Indonesia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.8.3.Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.9.Tacrolimus Market - South Korea
    • 8.5.9.1.South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9.2.South Korea.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.9.3.South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
• 8.6.Tacrolimus Market - Middle East & Africa
  • 8.6.1.Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6.2.Middle East & Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 8.6.3.Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.6.4.Tacrolimus Market - Saudi Arabia
    • 8.6.4.1.Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4.2.Saudi Arabia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.4.3.Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.6.5.Tacrolimus Market - UAE
    • 8.6.5.1.UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5.2.UAE.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.5.3.UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.6.6.Tacrolimus Market - Israel
    • 8.6.6.1.Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6.2.Israel.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.6.3.Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.6.7.Tacrolimus Market - South Africa
    • 8.6.7.1.South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7.2.South Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.7.3.South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
• 8.7.Tacrolimus Market - Latin America
  • 8.7.1.Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7.2.Latin America.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 8.7.3.Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.7.4.Tacrolimus Market - Mexico
    • 8.7.4.1.Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4.2.Mexico.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.4.3.Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.7.5.Tacrolimus Market - Brazil
    • 8.7.5.1.Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5.2.Brazil.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.5.3.Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.7.6.Tacrolimus Market - Argentina
    • 8.7.6.1.Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6.2.Argentina.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.6.3.Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)

9.Competitive Landscape

• 9.1.Expansion and Acquisition Analysis
  • 9.1.1.Expansion
  • 9.1.2.Acquisitions
• 9.2.Partnerships/Collaborations/Agreements/Exhibitions

10.Company Profiles

• 10.1.Astellas Pharma Inc
  • 10.1.1.Company Overview
  • 10.1.2.Financial Performance
  • 10.1.3.Product Benchmarking
  • 10.1.4.Recent Development
• 10.2.Biocon Ltd.
  • 10.2.1.Company Overview
  • 10.2.2.Financial Performance
  • 10.2.3.Product Benchmarking
  • 10.2.4.Recent Development
• 10.3.Dr. Reddy's Laboratories Ltd.
  • 10.3.1.Company Overview
  • 10.3.2.Financial Performance
  • 10.3.3.Product Benchmarking
  • 10.3.4.Recent Development
• 10.4.Glenmark Pharmaceuticals Inc
  • 10.4.1.Company Overview
  • 10.4.2.Financial Performance
  • 10.4.3.Product Benchmarking
  • 10.4.4.Recent Development
• 10.5.GlaxoSmithKline plc
  • 10.5.1.Company Overview
  • 10.5.2.Financial Performance
  • 10.5.3.Product Benchmarking
  • 10.5.4.Recent Development
• 10.6.LEO Pharma A/S
  • 10.6.1.Company Overview
  • 10.6.2.Financial Performance
  • 10.6.3.Product Benchmarking
  • 10.6.4.Recent Development
• 10.7.Novartis AG
  • 10.7.1.Company Overview
  • 10.7.2.Financial Performance
  • 10.7.3.Product Benchmarking
  • 10.7.4.Recent Development
• 10.8.Lupin Pharmaceuticals Inc.
  • 10.8.1.Company Overview
  • 10.8.2.Financial Performance
  • 10.8.3.Product Benchmarking
  • 10.8.4.Recent Development
• 10.9.Panacea Biotec
  • 10.9.1.Company Overview
  • 10.9.2.Financial Performance
  • 10.9.3.Product Benchmarking
  • 10.9.4.Recent Development
• 10.10.Pfizer Inc
  • 10.10.1.Company Overview
  • 10.10.2.Financial Performance
  • 10.10.3.Product Benchmarking
  • 10.10.4.Recent Development